The Prognostic Value of CD206 in Solid Malignancies: A Systematic Review and Meta-Analysis
Jens Debacker(Ghent University Hospital), Wouter Huvenne(Ghent University Hospital), Marleen Keyaerts(Vrije Universiteit Brussel), Odrade Gondry(Onze Lieve Vrouwziekenhuis Hospital), Tony Lahoutte(Vrije Universiteit Brussel)
Cited by 40
Related Papers
Phase I Study of [<sup>68</sup>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)
|Journal of Nuclear Medicine|2023|45
Phase II Trial Assessing the Repeatability and Tumor Uptake of [<sup>68</sup>Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma
|Journal of Nuclear Medicine|2024|40
Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab
|Annals of Oncology|2018|4
Baseline biomarkers correlated with outcome in advanced melanoma treated with pembrolizumab monotherapy.
|Journal of Clinical Oncology|2020|3